Shares of Biocon Ltd. rose 1.45% in intraday trade to Rs 370.06 apiece after the company announced the launch of Everolimus tablets, a generic version of Afinitor in the U.S., thereby expanding its generic formulations portfolio.
RBI Prepares To File For Insolvency Proceedings Against SREI Infrastructure Finance & SREI Equipment Finance
Reserve Bank of India prepares to file for insolvency proceedings against SREI Infrastructure Finance and SREI Equipment Finance RBI has finalised an administrator to be appointed …